Benitec Biopharma
BNTC
BNTC
25 hedge funds and large institutions have $5.92M invested in Benitec Biopharma in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.66% more ownership
Funds ownership: 0.96% → 3.63% (+2.7%)
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.72M | |
| 2 | +$578K | |
| 3 | +$479K | |
| 4 |
EAM
Empery Asset Management
New York
|
+$296K |
| 5 |
ACM
Altium Capital Management
New York
|
+$245K |
Top Sellers
| 1 | -$158K | |
| 2 | -$62K | |
| 3 | -$58K | |
| 4 |
VF
Virtu Financial
New York
|
-$55K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$28K |